1. A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study results. (26th October 2017) Authors: Spencer, Andrew; Harrison, Simon; Zonder, Jeffrey; Badros, Ashraf; Laubach, Jacob; Bergin, Krystal; Khot, Amit; Zimmerman, Todd; Chauhan, Dharminder; Levin, Nancy; MacLaren, Ann; Reich, Steven D.; Trikha, Mohit; Richardson, Paul Journal: British journal of haematology Issue: Volume 180:Number 1(2018) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16‐02 trial. (15th May 2021) Authors: Bergin, Krystal; Yuen, Flora; Wallington‐Beddoe, Craig; Kalff, Anna; Sirdesai, Shreerang; Reynolds, John; Spencer, Andrew Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma. Issue 12 (2nd December 2018) Authors: Yuen, Hiu Lam Agnes; Low, Michael Sze Yuan; Fedele, Pasquale; Kalff, Anna; Walker, Patricia; Bergin, Krystal; Coutsouvelis, John; Grigoriadis, George; Spencer, Andrew Journal: Leukemia & lymphoma Issue: Volume 59:Issue 12(2018) Page Start: 2842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry. Issue 1 (December 2016) Authors: Bergin, Krystal; Moore, Elizabeth; McQuilten, Zoe; Wood, Erica; Augustson, Bradley; Blacklock, Hilary; Ho, Joy; Horvath, Noemi; King, Tracy; McNeil, John; Mollee, Peter; Quach, Hang; Reid, Christopher; Rosengarten, Brian; Walker, Patricia; Spencer, Andrew Journal: BMC medical research methodology Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study). Issue 9 (29th July 2019) Authors: Kalff, Anna; Khong, Tiffany; Mithraprabhu, Sridurga; Bergin, Krystal; Reynolds, John; Bowen, Kathryn M.; Thakurta, Anjan; Guzman, Roberto; Wang, Maria; Couto, Suzana; Ren, Yan; Spencer, Andrew Journal: Leukemia & lymphoma Issue: Volume 60:Issue 9(2019) Page Start: 2143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR). (11th July 2022) Authors: McQuilten, Zoe; Wellard, Cameron; Moore, Elizabeth; Augustson, Bradley; Bergin, Krystal; Blacklock, Hilary; Harrison, Simon; Ho, P. Joy; King, Tracy; Quach, Hang; Mollee, Peter; Rosengarten, Brian; Walker, Patricia; Wood, Erica; Spencer, Andrew Journal: British journal of haematology Issue: Volume 198:Number 5(2022) Page Start: 830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing. Issue 2 (28th January 2021) Authors: Reale, Antonia; Khong, Tiffany; Mithraprabhu, Sridurga; Savvidou, Ioanna; Hocking, Jay; Bergin, Krystal; Ramachandran, Malarmathy; Chen, Maoshan; Dammacco, Francesco; Ria, Roberto; Silvestris, Francesco; Vacca, Angelo; Reynolds, John; Spencer, Andrew Journal: Leukemia & lymphoma Issue: Volume 62:Issue 2(2021) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Upfront tandem autologous non‐myeloablative allogeneic stem cell transplant in high‐risk multiple myeloma: a long‐term single‐centre experience. Issue 7 (9th July 2022) Authors: Nguyen, Phillip C.; Muirhead, Jenny; Tan, Joanne; Kalff, Anna; Bergin, Krystal; Walker, Patricia; Spencer, Andrew Journal: Internal medicine journal Issue: Volume 52:Issue 7(2022) Page Start: 1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗